(Report) 2nd Series on EOL (End of life) Care discussion
date : 10/23/2013
The first seminar opened interactive dialogue and discussion on how to materialize ideal End on Life Care not only by recognizing “end of life” just prior to death but also to embrace the timeframe and overview process of death as an “end of life”. Dr. Hiroko Akimoto, who is a professional of gerontology (aging study) and a director “Hana-no-tani Clinic” (Flower-Valley clinic), Dr. Mami Itoh were invited as guest lectures.
Dr. Akiyama elaborated a contextual example of how to design a life for extended life span and how to make a decision for end of life. Dr. Itoh on the other hand, opened “Hana-no-tani Clinic” near the shore of South Bōsō, Chiba prefecture in order to provide medical care that free from the boundaries of out-patient, home care, or hospice. She talked about why clinic like “Hana-no-tani” was needed and how to provide not only medical care but also to deliver life support.
———-
■Date: Oct 8 (Tuesday) 19:00-21:00
■Place: Marunouchi Building Hall&Conference Square (8F MarunouchiBuilding, 2-4-1 Marunouchi, Chiyoda-ku, Tokyo)
■Organized by: Health and Global Policy Institution, NPO
■Points of view: It allows multispectral speakers to exchange their opinions.
■Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (70 invitees)
■Participation fee:1,500Yen
Language: Japanese (No interpretation)
———-
Program
1. The 1st Review of EOL Seminar
2. Life Design and EOL Care of Hyper Aging Society
Speaker:
-Dr. Hiroko Akiyama(Project Proffessor, Executive associate member, Institute of Gerontology, the University of Tokyo)
-Dr. Mami Ito (Director of “Hana-no-tani”Clinic)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/Surgeon
Dr. Akiyama elaborated a contextual example of how to design a life for extended life span and how to make a decision for end of life. Dr. Itoh on the other hand, opened “Hana-no-tani Clinic” near the shore of South Bōsō, Chiba prefecture in order to provide medical care that free from the boundaries of out-patient, home care, or hospice. She talked about why clinic like “Hana-no-tani” was needed and how to provide not only medical care but also to deliver life support.
———-
■Date: Oct 8 (Tuesday) 19:00-21:00
■Place: Marunouchi Building Hall&Conference Square (8F MarunouchiBuilding, 2-4-1 Marunouchi, Chiyoda-ku, Tokyo)
■Organized by: Health and Global Policy Institution, NPO
■Points of view: It allows multispectral speakers to exchange their opinions.
■Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (70 invitees)
■Participation fee:1,500Yen
Language: Japanese (No interpretation)
———-
Program
1. The 1st Review of EOL Seminar
2. Life Design and EOL Care of Hyper Aging Society
Speaker:
-Dr. Hiroko Akiyama(Project Proffessor, Executive associate member, Institute of Gerontology, the University of Tokyo)
-Dr. Mami Ito (Director of “Hana-no-tani”Clinic)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/Surgeon
Exhibition date：2013-10-08
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] “Balancing Sustainability and Innovation in the Healthcare System” (December 26, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
![[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20260309-top.png)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
![[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/is-20260122-top_ENG.png)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
![[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”](https://hgpi.org/en/wp-content/uploads/sites/2/Eyecatch_Column_RD_2-1.png)
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
![[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/vc-20250425-top.jpg)
